Development of a type 2 diabetes risk model from a panel of serum biomarkers from the Inter99 cohort: response to Kolberg et Al

Diabetes Care. 2010 Feb;33(2):e28; author reply e29. doi: 10.2337/dc09-1780.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Adiponectin / blood
  • Area Under Curve
  • Biomarkers / blood*
  • Blood Glucose / metabolism
  • C-Reactive Protein / metabolism
  • Diabetes Mellitus, Type 2 / epidemiology*
  • Glycated Hemoglobin / metabolism
  • Humans
  • Lipids / blood
  • Risk Assessment

Substances

  • Adiponectin
  • Biomarkers
  • Blood Glucose
  • Glycated Hemoglobin A
  • Lipids
  • C-Reactive Protein